- Home
- IPI vs XNCR Comparison
IPI vs XNCR Comparison
Compare IPI & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPI
- XNCR
- Stock Information
- Founded
- IPI 2000
- XNCR 1997
- Country
- IPI United States
- XNCR United States
- Employees
- IPI N/A
- XNCR N/A
- Industry
- IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- IPI Industrials
- XNCR Health Care
- Exchange
- IPI Nasdaq
- XNCR Nasdaq
- Market Cap
- IPI 470.9M
- XNCR 547.8M
- IPO Year
- IPI 2008
- XNCR 2013
- Fundamental
- Price
- IPI $30.54
- XNCR $12.04
- Analyst Decision
- IPI Strong Sell
- XNCR Buy
- Analyst Count
- IPI 1
- XNCR 11
- Target Price
- IPI $23.00
- XNCR $22.20
- AVG Volume (30 Days)
- IPI 183.6K
- XNCR 1.2M
- Earning Date
- IPI 11-03-2025
- XNCR 11-05-2025
- Dividend Yield
- IPI N/A
- XNCR N/A
- EPS Growth
- IPI N/A
- XNCR N/A
- EPS
- IPI N/A
- XNCR N/A
- Revenue
- IPI $225,166,000.00
- XNCR $146,929,000.00
- Revenue This Year
- IPI $10.01
- XNCR $23.31
- Revenue Next Year
- IPI N/A
- XNCR N/A
- P/E Ratio
- IPI N/A
- XNCR N/A
- Revenue Growth
- IPI 10.53
- XNCR N/A
- 52 Week Low
- IPI $20.86
- XNCR $6.92
- 52 Week High
- IPI $39.01
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- IPI 52.58
- XNCR 80.54
- Support Level
- IPI $28.51
- XNCR $10.24
- Resistance Level
- IPI $30.96
- XNCR $12.63
- Average True Range (ATR)
- IPI 1.54
- XNCR 0.57
- MACD
- IPI 0.18
- XNCR 0.11
- Stochastic Oscillator
- IPI 55.70
- XNCR 76.73
About IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.